Paper Details

  1. Home
  2. Paper Details

Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer.

Author: BogartJeffrey A, StinchcombeThomas E

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

For patients with stage IIIA or stage IIIB non-small cell lung cancer, concurrent chemoradiotherapy has demonstrated superior overall survival compared to sequential chemotherapy and thoracic radiation therapy.
Paper Details　
Original Abstract of the Article :
Approximately one third of patients with non-small cell lung cancer have unresectable stage IIIA or stage IIIB disease, and appropriate patients are candidates for chemoradiotherapy with curative intent. The optimal treatment paradigm is currently undefined. Concurrent chemoradiotherapy, compared wi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360908/

データ提供：米国国立医学図書館（NLM）

Novel Approaches to Chemoradiotherapy for Non-Small Cell Lung Cancer

This research explores the challenging realm of non-small cell lung cancer (NSCLC), focusing on the development of novel strategies for treating unresectable stage IIIA and IIIB disease. The authors, like skilled desert navigators seeking the most effective route through a treacherous landscape, investigated the potential benefits of different chemoradiotherapy approaches for these advanced stages of lung cancer.

Optimizing Chemoradiotherapy

The study highlights the importance of optimizing chemoradiotherapy regimens to maximize effectiveness and minimize toxicity. This pursuit, much like a desert explorer searching for a source of water in a parched landscape, aims to identify the most effective treatment strategies for patients with NSCLC.

Promising New Approaches

The study underscores the potential benefits of newer chemotherapy combinations, such as cisplatin and pemetrexed, when combined with radiotherapy. This discovery, much like finding a hidden oasis with a refreshing spring, offers hope for patients with advanced NSCLC, providing a potentially more effective and less toxic treatment option.

Dr.Camel's Conclusion

This research underscores the importance of ongoing innovation in the treatment of lung cancer, offering a roadmap for developing more effective and personalized approaches. It's a testament to the relentless pursuit of better cancer treatments, much like the desert's resilience in the face of adversity.
Date :
  1. Date Completed 2013-01-10
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

22531360

DOI: Digital Object Identifier

PMC3360908

Related Literature

Article Analysis
・Effective treatment of lung cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.